Navigation Links
Partnerships Effective Communicators of Cancer Advances
Date:5/16/2008

Treatment guidelines quickly disseminated to community physicians, audit finds

FRIDAY, May 16 (HealthDay News) -- Partnerships between major academic cancer centers and community hospitals are a quick and effective way to spread cancer treatment advances, say researchers at Fox Chase Cancer Center in Philadelphia.

Most new cancer treatments are created at major academic centers and most cancer care is provided at community hospitals, noted the researchers, who conducted a quality control audit of hospitals associated with Fox Chase, a U.S. National Cancer Institute-designated Comprehensive Cancer Center.

The 26 hospitals that are part of the Fox Chase Partners Program have access to the most recent cancer treatment guidelines developed by Fox Chase and other member institutions of the National Comprehensive Cancer Network (NCCN).

"When research leads to significant changes in treatment, it can take years before community oncologists are able to fully adopt the new guidelines. What's unique about the (Fox Chase) Partners program is the timely transition of advances. The audit we conducted shows that our Partner physicians are highly compliant in incorporating recent advances in cancer treatment," Margaret O'Grady, director of care management and clinical operations of Fox Chase Cancer Partners, said in a prepared statement.

She and her colleagues reviewed the medical charts of 124 patients, age 65 or older, treated for stage III colon cancer at Partner hospitals between 2003 and 2006, and found high compliance with NCCN treatment guidelines, including obtaining a minimum of 12 lymph nodes at surgery, and the addition of oxaliplatin to adjuvant chemotherapy.

Almost all patients (123) received adjuvant chemotherapy, although only 76 (61 percent) received oxaliplatin, a chemotherapy agent shown to extend survival in this group of patients.

"At first glance, this number looked low, but as we probed further, we found that all but 11 patients who didn't receive oxaliplatin had documented co-morbidities or other concerns that precluded them from receiving this treatment," O'Grady said.

The audit also found that 74 percent of patients had at least 12 lymph nodes retrieved, which is critically important to cancer treatment planning.

Nearly all the patients (93 percent) received appropriate surveillance with history and physical exams at suggested intervals and routine CEA testing. Abdominal and pelvic surveillance CT was performed in 78 percent of patients.

"We found a drop-off in compliance (49 percent) regarding the documentation of discussions between the doctor and patient about age and life expectancy in relation to adjuvant chemotherapy," O'Grady said. "This discussion is important and informs decision-making."

More information

The U.S. National Cancer Institute has more about cancer therapy.



-- Robert Preidt



SOURCE: Fox Chase Cancer Center, news release, May 15, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas, April 14 - 16, 2008.
2. Northwestern Memorial Hospital, CAPS, and p4ps Host Consumer Forum to Advance Partnerships to Improve Healthcare Patient Safety
3. Partnerships Report Highlights How Blue Cross Blue Shield of Michigan, Physicians and Hospitals Are Working to Save Lives, Improve Care, Reduce Costs
4. Snap Fitness Launches Partnerships with Leading Online Health & Fitness Companies
5. On World AIDS Day, Keeping the Promise to Stop AIDS Through the Power of Partnerships
6. First-Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions
7. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
8. MGT Capital Investments Announces New Commercial Partnerships for Subsidiary Company Medicexchange PLC
9. Ingenious Med Forms Multiple Billing Company Partnerships to Market Inpatient Practice Management Solutions
10. Study shows that administering calcium and magnesium effectively reduces neurological sensitivity
11. Partnership of academic centers and community hospitals effective model for disseminating advances
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of ... pain with a reputable physician in their area, announces the launch of a new ... for patients who are looking for reputable physicians to help them with back or ...
(Date:4/25/2017)... NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed ... treatment of acute or chronic problems, I focus on preventative care with all my patients ... you have any questions, always feel free to contact my office and my trained staff ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol ... is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex ... in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College ... nursing professionals advance their careers. Beginning in the fall of 2017, Emmanuel’s program will ... in as few as 16 months and for as little as $14,528. These changes ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... YORK , April 19, 2017 Global ... drainage devices are tubes used to remove excess liquid ... blood, serum, pus, urine, bile or lymph. Surgical drains ... of surgery such as orthopedics surgery, cardiovascular surgery, neurosurgery, ... is prophylactic post-surgery to prevent accumulation of fluid e.g. ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... 2017 Cogentix Medical, Inc. (NASDAQ: CGNT), a ... Uro/Gyn and Gynecology markets with innovative and proprietary products, ... March 31, 2017 after the market close on Tuesday, ... host a conference call and webcast to discuss its ... 2017 at 4:30 p.m. Eastern Time (3:30 p.m. Central ...
Breaking Medicine Technology: